|Year : 2017 | Volume
| Issue : 4 | Page : 348-352
The first positive serological study on rift valley fever in ruminants of Iran
Shahin Fakour1, Salahedin Naserabadi1, Elham Ahmadi2
1 Department of Clinical Sciences, Sanandaj Branch, Islamic Azad University, Iran
2 Departments of Microbiology, Sanandaj Branch, Islamic Azad University, Iran
|Date of Submission||01-Feb-2017|
|Date of Acceptance||27-Nov-2017|
|Date of Web Publication||19-Feb-2018|
Department of Clinical Sciences, Faculty of Veterinary Medicine, Islamic Azad University–Sanandaj Branch
Source of Support: None, Conflict of Interest: None
Background & objectives: Rift Valley fever (RVF) is a zoonotic vector-borne disease that primarily affects domestic animals but can also infect humans. The purpose of the present study was to investigate the presence of antibodies against RVF virus (RVFV) in ruminants, viz. cattle, sheep, and goats in Kurdistan Province of western Iran.
Methods: Blood samples were collected from 288 ruminants (118 cattle, 142 sheep and 28 goats) of both sexes, under age groups ≤1, 1–3, 3–5 and ≥5 yr, from January 2016 to December 2016. Clinical symptoms and history of abortion were recorded. The presence of RVFV-specific antibodies was investigated by using ELISA (competitive) and indirect immunofluorescence assay (IIFA) after separation of serum.
Results: The results of two tests were positive for five (1.74%) of total 288 animals which included two cattle of 118 (1.7%), and three sheep of 142 (2.11%). The results of IIFA were correlated with the ELISA results. All animals were clinically normal. No significant relationship between the RVFV infection rate and the variable considered, i.e. season, animal’s age or sex, and the species of the animal (p ≥ 0.05), although there were four seropositive animals in the age group 1–3 and five seropositive animals in the spring season.
Interpretation & conclusion: The results of the study revealed the presence of low-level RVFV circulation among the ruminants of Kurdistan Province in Iran indicating that they are at risk of exposure to the virus during their lifetime. Since the present study was the first serological study on RVF in Iran with positive results, further studies are suggested including other areas of Iran.
Keywords: ELISA; Iran; RVF disease; serology
|How to cite this article:|
Fakour S, Naserabadi S, Ahmadi E. The first positive serological study on rift valley fever in ruminants of Iran. J Vector Borne Dis 2017;54:348-52
|How to cite this URL:|
Fakour S, Naserabadi S, Ahmadi E. The first positive serological study on rift valley fever in ruminants of Iran. J Vector Borne Dis [serial online] 2017 [cited 2018 May 21];54:348-52. Available from: http://www.jvbd.org/text.asp?2017/54/4/348/225840
| Introduction|| |
Rift Valley fever virus (RVFV) is a mosquito-borne virus, and is the causative agent of Rift Valley fever (RVF), a zoonotic disease characterized by an increased incidence of abortion or fetal malformation in ruminants occurring in epizootic periods associated with heavy rainfall . Infection in humans can also lead to clinical manifestations that in severe cases cause encephalitis or hemorrhagic fever. The virus is endemic throughout much of the African continent. However, the emergence of RVFV in the Middle East, northern Egypt and the Comoros Archipelago has highlighted its geographical range expansion, increasing the concerns over the potential for further incursion into Europe,. It extends from Syria in the Middle East, right down to Mozambique in southeastern Africa.
RVF virus belongs to the Bunyaviridae family within the genus Phlebovirus. It is an enveloped virus containing a capsid and single-stranded RNA genome. Young animals are significantly more susceptible and a lot more likely to die. Severity of the disease varies by species, with lambs being “extremely susceptible”, calves “highly susceptible” and humans “moderately susceptible”,,.
Animals and human become infected through a bite from an infected mosquito, and there are a number of mosquito vectors that have been shown to transmit RVFV, predominantly of the Culex and Aedes genera. Other modes of transmission include animal-to-animal infection through direct contact with infected tissues or fluids, through the re-use of needles during vaccination; particularly in regions with limited resources. The lactating animals may also potentially infect their young ones via milk feeding.
Clinical signs of RVF tend to be nonspecific, which make individual cases difficult to diagnose, but high levels of mortality in young animals, high abortion rates and flu-like symptoms in humans are major indications of the infection. Clinical signs in young animals include fever, lethargy and listlessness, abdominal pain, nasal discharge, anorexia, bloody/fetid diarrhoea, abortion and mortality.
In adult sheep and cattle, abortion is the outstanding sign, but the mortality rate in adult sheep is higher (20–30%) than in cattle (10%). In less severe cases in cattle there is febrile disease and disagalactia and some animals develop emaciation with jaundice. In fatal cases, sudden death is preceded by a high fever for 1–2 days. Several veterinarians and veterinary staff were infected after handling and performing necropsies on animals that were only later identified as infected with RVF virus.
Under the surveillance plan from 2001 to 2011, samples from different animals like sheep, goats, cattle, and camels including clinically suspected humans were examined for RVFV in the nine provinces of Iran through a seroepidemiological study. None of the animal or human samples were found positive for the virus. However, successive surveillance and monitoring of diseases like RVF is necessary for the prevention of the potential introduction of such uninvited zoonosis [by simple transfer of disease-vector mosquitoes through wind or air currents and travel of many pilgrims (Hajj yatra)], as Iran lies in close proximity to the ‘hot spot countries’ Saudi Arabia, Iraq and Yemen. This trend become more pronounced by purchase of remnants, including sheep and cattle, from Iraq as well as formal and informal exchanges of these animals in the border areas of Kurdistan, Kermanshah, Il-lam, East Azerbaijan provinces in the northwest and west provinces of Iran. In the year 2000, the disease outbreak was reported for animals and humans in Saudi Arabia. The result of the study carried out by Muhsen in the year 2010 on 1215 sheep serums in Iraq revealed a seropositivity of 8.88%. This can be considered as warning sign for the circulation of the virus in the different areas for Iran or its proximity,,. Several species of Culicidae family are identified as disease-vector mosquito in the different studies that have been carried out in Iran, especially the western provinces of Iran such as Kurdistan and Kermanshah. This fact increases the possibility, in terms of the disease spread, because there is a network of irrigation canals for agriculture in Iraq unlike other countries that creates the field of mass propagation of mosquitoes. It seems that the risk of developing the disease in Iran is not unexpected due to the expansion of Iran’s borders with Iraq.
The aim of the present study was to investigate the presence of antibodies against RVFV in three species of ruminants (cattle, sheep and goats) in Iran’s Kurdistan Province, while recording the clinical symptoms and history of animal abortion. This is the first study to determine antibodies against RVFV and report positive serology in animals of Iran.
| Material & Methods|| |
The major prevailing ruminants (cattle, sheep and goats) of both sexes, i.e. male and female in the age groups of ≤1 yr, 1–3, 3–5 and ≥5 yr-old, were selected randomly during winter, spring, summer and autumn of the year (from January 2016 to December 2016) in Kurdistan Province located in western Iran. This cross-sectional study was focused on the border area of Kurdistan Province, Iran.
At first, clinical examination was performed including mucosa, lymph nodes, body temperature, heart rate, respiratory rate and the history of abortion in herd based on a previously prepared questionnaire. Next, 10 ml blood was taken from the animals’ jugular veins using sterile syringes and serum tubes without additives.
All animals used in the experiments were handled in compliance with the Guide of National Institute of Health, USA for the care and use of laboratory animals, and the study was approved by the local ethical committee.
Serum samples were separated and were kept frozen at -20°C. Separated serums were tested serologically using competitive ELISA (ID Screen® Rift Valley Fever Competition Multi-Species ID-Vet, Grables, France), which detects both IgG and IgM antibodies directed against the nucleoprotein of RVFV. This test has been shown to have a high sensitivity (91–100%) and a high specificity (100%) in both tests done by the manufacturer and an independent ring trial. The competitive ELISA was performed according to the instructions of the manufacturer and all samples were run once. The absorbance was read at 450 nm. To control the validity of each plate, the mean value of the two negative controls (ODNC) were calculated and the plate was considered valid when ODNC >0.7. For a valid plate, the mean value of the two positive controls divided by ODNC should be <0.3. For each sample the competition percentage was calculated by dividing (ODsample/ODNC) χ 100. If the value was ≤40%, the sample was considered positive. A value ≥50% was a negative result and the values in between 40 and 50% indicated a doubtful result.
Additional confirmation of positive results in previous test was performed with indirect immunofluorescence assay (IIFA). All collected sera were screened for anti-RVFV IgG antibodies by IIFA using a modified commercial RVFV IIFA slide test kit (Euroimmun, Lübeck, Germany). Slides containing a mixture of infected and non-infected Vero E6 cells on one field (positive field) and non-infected Vero E6 cells on a negative control field were used. Sheep, goat and cattle sera were diluted 1: 100 with sampling buffer, and 25 μl of the diluted samples were applied to a biochip and incubated for 30 min at room temperature. After a first washing step for 10 min with phosphate-buffered saline (PBS), pH 7.2; 0.2% Tween 20, 25 μl of donkey anti-sheep IgG Cy3 (Indocarbocyanin)- labelled antibodies (Dianova, Hamburg, Germany) was used for small ruminants and goat anti-bovine IgG Cy3-labelled antibodies (Dianova) for cattle samples, respectively. After the second incubation step at room temperature in the dark for 30 min, the slides were washed again for 10 min, dried and covered with sampling buffer and cover plates. Slides were then examined on a fluorescence microscope.
Statistical analysis was performed using SPSS Version 21 software in order to determine the prevalence of the RVF in the study sera. The association between the RVF variable and the variables of clinical findings including age, sex, season, and species were screened using Chi-square (χ2) statistical test. The p-values ≤ 0.05 were considered statistically significant.
| Results|| |
A total of 288 ruminants (118 cattle, 142 sheep and 28 goats) were examined for RVFV seropositivity. The results of competitive ELISA and IIFA tests were positive for five (1.74%) of the 288 animals which included two cattle of 118 (1.7%), and three sheep of 142 (2.11%). None of the animals, seropositive to RVF showed clinical symptoms related to the disease. The results of this study did not show any statistically significant relationship between serologic test and season, age, sex, and the animal’s species variables (p ≥ 0.05). The results are shown in [Table 1].
|Table 1: The results of serology tests (competitive ELISA and IIFA) for animals tested|
Click here to view
| Discussion|| |
In recent years, the distribution and nature of RVF has changed significantly. It has become a great veterinary concern to dairy producers, wildlife managers and veterinary diagnosticians because of the frequent occurrence of sporadic cases and outbreaks among domestic and wild ruminants. Very little information is available about the epidemiology and disease potential of RVF in Iran’s domestic livestock.
In this study, five of the total 288 animals studied were found positive in serology tests done using competitive ELISA and IIFA. The IIFA, which has been designed for the human diagnostic market, was adapted for serological testing on animals, and the results obtained clearly correlated with that of the ELISA. In other words, 1.74% of animals had a report of RVF infection. The present study is the first research on seroprevalence of RVFV in Iran reporting positive serological results, indicating the presence of virus in the region under study.
Increasing formal and informal exchanges of animals in border areas of the Kurdistan Province of Iran, with Iraq, and increasing annual pilgrimages to the neighboring countries such as Iraq and Saudi Arabia and the focusing on border areas of the Kurdistan Province for sampling might be the reasons for the positive results in this study. There are a number of mosquito species, predominantly in Culex and Aedes genera that have been identified as vector of RVFV in Kurdistan and Khuzestan provinces in Iran,, which can be a serious threat for animals and humans.
In this study, no significant relationship was observed between season and age with serologic test of RVFV. Four seropositive animals were in the age group 1–3 and all five seropositive cases were observed in samples of the spring season. In this age and season, the animals are usually released into the pasture for grazing, where they are likely to be exposed to infected mosquitoes and subsequent RVFV infection.
The lack of significant relationship between animal species and the results of the serologic test is consistent with another seroprevalence study on RVF carried out by Aghaa and Rhaymah. Although no significant relationship was obtained between sex and serologic test, four cases of seropositive animals were female. Abortion is the most important clinical symptom of RVF in animals. At the time of sampling, the animals with an abortion history were sampled more often.
The outbreak in Saudi Arabia and Yemen in 2000 resulted in the death of an estimated 40,000 animals from a range of species, with 8000–10,000 abortions in ruminants. Uncontrolled movement of livestock during an outbreak is responsible for introducing RVF to new areas. For example, the virus that caused the Saudi Arabia’s outbreak in 2000 was found to be the same strain that caused the 1997–98 outbreaks in East Africa,. Therefore, an incursion of this zoonotic virus into Europe and the Middle East could potentially have a devastating impact on the livestock industry in multiple countries, along with a significant impact on animal and human health.
In a serological study conducted on some ruminants in north Turkey, no positive case was reported. But in two serological studies carried out in Iraq (the western neighborhood of Iran and Kurdistan Province of Iran), the tests revealed positive results for 1215 sheep samples (8.88%) in the Basrah and 368 goat samples (2.99%) in Ninevah Provinces,,. Another study carried out in Saudi Arabia (the southwestern neighborhood of Iran) reported the first outbreak of RVF and identified Aedes mosquitoes in the cities of Asir, Jizan, and Mecca highlighting the aspects of spread of RVF in Iran. RVFV also, has the potential for further internal spread particularly with the climate changes that might be expected with global warning. High risk receptive areas are, for example, the Tigris/Euphrates Delta zone to the northeast in Iraq and the Islamic Republic of Iran.
| Conclusion|| |
The results of this study revealed the presence of animals seropositive to RVFV which indicates that the virus is circulating (through in low-level) among the ruminants in Iran’s Kurdistan Province. The results indicate that animals are at risk of RVFV exposure in the study area. Since, the present study is the first serological study on RVF prevalence in Iran, with a positive result; therefore, it is suggested to perform further studies on animals and humans in other areas of Iran using isolation and serological methods.
Conflict of interest
All of the authors declare that they have no conflict of interest.
| Acknowledgements|| |
The authors gratefully acknowledge the financial support by Islamic Azad University–Sanandaj Branch, Iran.
| References|| |
Wensman J, Lindah J, Watchmeister N, Torsson E, Gwakisa P, Kasanga CH. A study of Rift valley fever virus in Morogoro and Arusha regions of Tanzania- serology and farmers’ perceptions. Infect Ecol Epidemiol
30025. doi: 103402/ee.v5.30025.
Karen LM , Ashley CB, Lorraine Mc, Nicholas J, Daniel L. Horton Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe. Vaccine
2015; 55(42): 5520-55.
Wilson W, McVey DC, Drolet BS, Weingartl H, Madden D. Rift Valley fever virus structural and non-structural proteins: Recombinant protein expression and immunoreactivity against antisera from sheep. Vector Borne Zoonotic Dis
Sindato C, Dirk U, Pfeiffer ED, Karimuribo EG, Mboera M, Rweyemamu M. A spatial analysis of Rift Valley fever virus seropositivity in domestic ruminants in Tanzania. PLoS
Di Nardo A, Rossi D, Saleh SML, Lejlifa SM, Hamdi SJ, Di Gennaro A. Evidence of Rift Valley fever seroprevalence in the Sahrawi semi-nomadic pastoralist system, Western Sahara. BMC Vet Res
Dulal P, Wright D, Ashfield R, Hill AVS, Charleston B, Warim-we GM. Potency of a thermostabilised chimpanzee adenovirus Rift Valley vever vaccine in cattle. Vaccine
2016; 34(20): 2296-322.
Warimwe GM, Gesharisha J, Carr BV, Otieno S, Otingah K, Wright D. Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever. Sci Rep
Radostits OM, Gay CC, Hinchcliff KW, Constable RD. Veterinary medicine: A textbook of the diseases of cattle, horses, sheep, pigs and goats
. X edn. London, UK: Saunders Elsevier Company 2014; p. 1205-7.
Ahmed KS. Observation on Rift valley fever virus and vaccines in Egypt. Virol J
Chinikar S, Shah-Hosseini N, Mostafavi E, Moradi M, Khakifirouz S, Jalali T, et al
. Surveillance of Rift Valley fever in Iran between 2001 and 2011. All Res J Biol
2013; 4(2): 16-8.
Muhsen RK. Seroepidemiology of Rift Valley fever in Basrah. Kufa J Vet Med Sci
2012; 3(2): 91-5.
Al-Afaleq AI, Hussein MF, Al-Naeem AA, Housawi F, Kabati AG. Seroepidemiological study of Rift Valley fever (RVF) in animals in Saudi Arabia. Trop Anim Health Prod
Aghaa OBS, Rhaymah MS. Seroprevalence study of Rift Valley fever antibody in sheep and goats in Ninevah governorate. Iraqi J Vet Sci
Moosa-Kazemi SH, Zahirnia AH, Sharifi F, Davari B .The Fauna and ecology of mosquitoes (Diptera: Culicidae) in Western Iran. J Arthropod Borne Dis
2015; 9(1): 49-59.
El Mamy AB, Thiongane Y, Diop M, Isselmou K, Doumbia B, Baba MO, et al
. Comprehensive phylogenetic reconstructions of Rift Valley fever virus: The 2010 northern Mauritania outbreak in the Camelus dromedarius
species. Vector Borne Zoonotic Dis
2014; 14(12): 856-61.
Jackel S, Eiden M, EL Mamy BO, Isselmon K, Vina-Rodrigues A, Doumbia B, et al
. Molecular and serological studies on the rift valley fever outbreak in Mauritania in 2010. Transbound Emerg Dis
(Suppl 2): 31-9.
Maiy MM, Ibrahim A, Tamadur MA, Sanaa AA, Mohamed E, Ahmed E. A survey of rift valley fever and associated risk factors among the one-humped camel (Camelus dromedaries)
in Sudan. Irish Vet J
6. doi: 10.1186/s13620-016-0065-6.
Azari-Hamidian S. Checklist of Iranian mosquitoes (Diptera: Culicidae). J Vector Ecol
2007; 32(2): 235-42.
Navidpour S, Vazirianzadeh B, Harbach R, Jahanifard E, Moravvej SA. The identification of culicine mosquitoes in the Shadegan wetland in Southwestern Iran. J Insect Sci
Himeidan YE, Kweka EJ, Mahgoub MM, El Rayah el A, Ouma JO. Recent outbreaks of Rift Valley fever in East Africa and the Middle East. Front Public Health
Mohammed Al-H, Ephraim A, Mahmoud A, Subodh B. Epidemic Rift Valley fever in Saudi Arabia: A clinical study of severe illness in human. Clin Infect Dis
Albayrak H, Ozan E. Seroepidemiological study of West Nile virus and Rift Valley fever virus in some of Mammalian species (herbivores) in northern Turkey. J Arthropod Borne Dis
2013; 7(1): 90-3.
Barry RM, Marvin SG, Mary BC, Harry MS, Yagob MM, Jeffri H, et al
. Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis
, Kingdom of Saudi Arabia. Emerg Infect Dis
2002; 8(12): 1492-4.
Geering WA, Davies FG, Vincent M. Preparation of Rift Valley fever (RVF) contingency plans. FAO Animal Health Manual
. Rome, Italy: Food and Agriculture Organization of the United Nations 2002; 15: